ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/09/14 | 1,930 | 1,979 | 1,924 | 1,973 | +23 | +1.2% | 580,800 |
| 2021/09/13 | 1,930 | 1,965 | 1,911 | 1,950 | +15 | +0.8% | 960,900 |
| 2021/09/10 | 1,955 | 1,955 | 1,917 | 1,935 | +14 | +0.7% | 437,000 |
| 2021/09/09 | 1,936 | 1,951 | 1,916 | 1,921 | -23 | -1.2% | 346,800 |
| 2021/09/08 | 1,929 | 1,970 | 1,918 | 1,944 | -20 | -1% | 676,300 |
| 2021/09/07 | 1,902 | 1,968 | 1,892 | 1,964 | +76 | +4% | 987,200 |
| 2021/09/06 | 1,870 | 1,894 | 1,834 | 1,888 | +29 | +1.6% | 642,700 |
| 2021/09/03 | 1,805 | 1,860 | 1,803 | 1,859 | +75 | +4.2% | 965,100 |
| 2021/09/02 | 1,794 | 1,801 | 1,773 | 1,784 | -10 | -0.6% | 289,800 |
| 2021/09/01 | 1,778 | 1,796 | 1,771 | 1,794 | +22 | +1.2% | 266,000 |
| 2021/08/31 | 1,773 | 1,788 | 1,758 | 1,772 | -8 | -0.4% | 423,500 |
| 2021/08/30 | 1,768 | 1,801 | 1,758 | 1,780 | +12 | +0.7% | 442,100 |
| 2021/08/27 | 1,743 | 1,771 | 1,734 | 1,768 | +27 | +1.6% | 421,000 |
| 2021/08/26 | 1,697 | 1,753 | 1,695 | 1,741 | +56 | +3.3% | 484,100 |
| 2021/08/25 | 1,720 | 1,720 | 1,674 | 1,685 | -40 | -2.3% | 499,500 |
| 2021/08/24 | 1,715 | 1,726 | 1,696 | 1,725 | +14 | +0.8% | 284,900 |
| 2021/08/23 | 1,722 | 1,735 | 1,704 | 1,711 | +25 | +1.5% | 271,400 |
| 2021/08/20 | 1,721 | 1,745 | 1,680 | 1,686 | -39 | -2.3% | 529,600 |
| 2021/08/19 | 1,685 | 1,757 | 1,683 | 1,725 | +28 | +1.6% | 648,800 |
| 2021/08/18 | 1,663 | 1,705 | 1,642 | 1,697 | +17 | +1% | 608,700 |
| 2021/08/17 | 1,698 | 1,729 | 1,673 | 1,680 | -18 | -1.1% | 824,500 |
| 2021/08/16 | 1,659 | 1,722 | 1,631 | 1,698 | +30 | +1.8% | 850,600 |
| 2021/08/13 | 1,610 | 1,693 | 1,605 | 1,668 | +119 | +7.7% | 1,523,500 |
| 2021/08/12 | 1,572 | 1,579 | 1,543 | 1,549 | -28 | -1.8% | 486,600 |
| 2021/08/11 | 1,580 | 1,603 | 1,572 | 1,577 | -12 | -0.8% | 460,700 |
| 2021/08/10 | 1,567 | 1,599 | 1,561 | 1,589 | +23 | +1.5% | 485,700 |
| 2021/08/06 | 1,590 | 1,609 | 1,564 | 1,566 | -27 | -1.7% | 428,500 |
| 2021/08/05 | 1,570 | 1,615 | 1,568 | 1,593 | +5 | +0.3% | 329,600 |
| 2021/08/04 | 1,636 | 1,644 | 1,587 | 1,588 | -61 | -3.7% | 608,000 |
| 2021/08/03 | 1,686 | 1,686 | 1,640 | 1,649 | -14 | -0.8% | 256,400 |
| 2021/08/02 | 1,653 | 1,670 | 1,631 | 1,663 | +13 | +0.8% | 282,100 |
| 2021/07/30 | 1,688 | 1,692 | 1,633 | 1,650 | -58 | -3.4% | 440,300 |
| 2021/07/29 | 1,700 | 1,709 | 1,674 | 1,708 | +37 | +2.2% | 320,100 |
| 2021/07/28 | 1,712 | 1,729 | 1,666 | 1,671 | -54 | -3.1% | 420,100 |
| 2021/07/27 | 1,770 | 1,770 | 1,714 | 1,725 | -32 | -1.8% | 350,500 |
| 2021/07/26 | 1,766 | 1,775 | 1,755 | 1,757 | +6 | +0.3% | 234,000 |
| 2021/07/21 | 1,747 | 1,770 | 1,732 | 1,751 | +39 | +2.3% | 441,700 |
| 2021/07/20 | 1,734 | 1,744 | 1,695 | 1,712 | -37 | -2.1% | 444,000 |
| 2021/07/19 | 1,738 | 1,768 | 1,727 | 1,749 | +12 | +0.7% | 328,400 |
| 2021/07/16 | 1,733 | 1,757 | 1,726 | 1,737 | +6 | +0.3% | 243,500 |
| 2021/07/15 | 1,792 | 1,793 | 1,729 | 1,731 | -45 | -2.5% | 374,200 |
| 2021/07/14 | 1,751 | 1,790 | 1,751 | 1,776 | +16 | +0.9% | 320,000 |
| 2021/07/13 | 1,736 | 1,772 | 1,736 | 1,760 | +9 | +0.5% | 357,700 |
| 2021/07/12 | 1,731 | 1,770 | 1,726 | 1,751 | +55 | +3.2% | 461,000 |
| 2021/07/09 | 1,690 | 1,728 | 1,671 | 1,696 | -20 | -1.2% | 840,700 |
| 2021/07/08 | 1,785 | 1,785 | 1,696 | 1,716 | -109 | -6% | 2,448,400 |
| 2021/07/07 | 1,810 | 1,837 | 1,796 | 1,825 | +7 | +0.4% | 403,300 |
| 2021/07/06 | 1,830 | 1,847 | 1,803 | 1,818 | -1 | -0.1% | 366,300 |
| 2021/07/05 | 1,870 | 1,872 | 1,818 | 1,819 | -38 | -2% | 452,800 |
| 2021/07/02 | 1,856 | 1,863 | 1,827 | 1,857 | ±0 | ±0% | 569,900 |
751～
800
件表示中 / 4944件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 125,100円 | +197.7% | - | 0.00% | 51.12倍 | 1.63倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 杏林製薬 | 153,100円 | +3.2% | +4.5% | 3.40% | 17.59倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 246,000円 | +7.6% | +57.5% | 2.15% | 19.02倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
